Cantourage Unlocks Personalized Cannabis: The Blue Dream Shift
In a strategic pivot that signals a major shift in the European medical cannabis landscape, Berlin-based Cantourage Group SE has announced a significant expansion of its active ingredient portfolio. By introducing new crude extract and distillate products derived from ‘Blue Dream’ genetics, the company is moving beyond the standard bulk-flower distribution model. This development provides…

